Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05818072 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 11, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Feb 28, 2025 to Dec 31, 2025
    • Study completion date: Feb 28, 2026 to Dec 31, 2026
    • Start date changed from estimate of Apr 30, 2023 to Mar 13, 2023
    • Interventions: Different biopsy protocol for patients with suspected Barrett's Esophagus (Diagnostic Test) to Endoscopy (Device), One biopsy (Procedure), Seattle protocol (Procedure), Three biopsy (Procedure)
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
E-DA Hospital
7 trials monitored
See 1 trial at risk
Detections of goblet cells and dysplasia are crucial for diagnosis and determining the surveillance program of Barrett's esophagus (BE). However, the optimal biopsy numbers and their yield rates of intestinal metaplasia (IM) and dysplasia are still uncertain, especially in Asia. The aim of this study was to determine the optimal biopsy protocol of BE.
Trial Details
NCT Number NCT05818072
Lead Sponsor E-DA Hospital
Conditions
(from sponsor)		 Barrett's Esophagus, Intestinal Metaplasia
Related terms Barrett Esophagus
Enrollment 165 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov